148 related articles for article (PubMed ID: 16933313)
21. Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck.
Shehadeh NJ; Ensley JF; Kucuk O; Black C; Yoo GH; Jacobs J; Lin HS; Heilbrun LK; Smith D; Kim H
Head Neck; 2006 Dec; 28(12):1090-8. PubMed ID: 16933316
[TBL] [Abstract][Full Text] [Related]
22. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer.
Patel UA; Patadia MO; Holloway N; Rosen F
Laryngoscope; 2009 Mar; 119(3):528-33. PubMed ID: 19160390
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
24. Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancers.
Hitchcock YJ; Bentz BG; Sharma PK; Fang C; Tward JD; Pappas L; Chen J; Hayes JK; Shrieve DC
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):422-7. PubMed ID: 17765769
[TBL] [Abstract][Full Text] [Related]
25. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of head and neck squamous cell carcinoma patients with N3 neck disease treated primarily with chemoradiation versus surgical resection.
Smyth JK; Deal AM; Huang B; Weissler M; Zanation A; Shores C
Laryngoscope; 2011 Sep; 121(9):1881-7. PubMed ID: 21997727
[TBL] [Abstract][Full Text] [Related]
27. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.
Goguen LA; Posner MR; Tishler RB; Wirth LJ; Norris CM; Annino DJ; Sullivan CA; Li Y; Haddad RI
Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):526-31. PubMed ID: 16702569
[TBL] [Abstract][Full Text] [Related]
28. Management of cervical metastases in advanced squamous cell carcinoma of the tonsillar fossa following radiotherapy.
Mau T; Oh Y; Bucci MK; Eisele DW
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):600-4. PubMed ID: 16027282
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
[TBL] [Abstract][Full Text] [Related]
30. Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer.
Cupino A; Axelrod R; Anne PR; Sidhu K; Lavarino J; Kung B; Rosen M; Keane W; Machtay M
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):416-21. PubMed ID: 17765768
[TBL] [Abstract][Full Text] [Related]
31. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group.
Vedrine PO; Thariat J; Hitier M; Janot F; Kaminsky MC; Makeieff M; De Raucourt D; Lapeyre M; Toussaint B;
Laryngoscope; 2008 Oct; 118(10):1775-80. PubMed ID: 18806474
[TBL] [Abstract][Full Text] [Related]
32. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
[TBL] [Abstract][Full Text] [Related]
33. Prospective study on neck dissection after primary chemoradiation therapy in stage IV pharyngeal cancer.
Bremke M; Barth PJ; Sesterhenn AM; Budach V; Engenhart-Cabillic R; Werner JA
Anticancer Res; 2009 Jul; 29(7):2645-53. PubMed ID: 19596941
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of patients with n3 neck nodes treated with chemoradiation.
Ballonoff A; Raben D; Rusthoven KE; Bassetti M; Kane M; Song JI; Chen C
Laryngoscope; 2008 Jun; 118(6):995-8. PubMed ID: 18364595
[TBL] [Abstract][Full Text] [Related]
35. High-dose-rate brachytherapy plus neck dissection for nodal disease.
Beitler JJ; Garg M; Owen RP; Sarta C; Yaparpalvi R; Smith RV
Head Neck; 2008 Jul; 30(7):933-8. PubMed ID: 18327781
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic management of upper esophageal strictures after treatment of head and neck malignancy.
Ahlawat SK; Al-Kawas FH
Gastrointest Endosc; 2008 Jul; 68(1):19-24. PubMed ID: 18355822
[TBL] [Abstract][Full Text] [Related]
37. The role of neck dissection in the combined modality therapy setting.
Brown KM; Lango M; Ridge JA
Semin Oncol; 2008 Jun; 35(3):229-35. PubMed ID: 18544438
[TBL] [Abstract][Full Text] [Related]
38. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
Fortin A; Caouette R; Wang CS; Vigneault E
Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
[TBL] [Abstract][Full Text] [Related]
39. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Mendenhall WM; Villaret DB; Amdur RJ; Hinerman RW; Mancuso AA
Head Neck; 2002 Nov; 24(11):1012-8. PubMed ID: 12410537
[TBL] [Abstract][Full Text] [Related]
40. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
Lango MN; Andrews GA; Ahmad S; Feigenberg S; Tuluc M; Gaughan J; Ridge JA
Head Neck; 2009 Mar; 31(3):328-37. PubMed ID: 18853450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
